Yes, we got a better deal for RoW compared to US due to the timing of it. The drug is likely to fetch a lower price in the EU though. I would imagine that long term EU should be similar market size to the US. More patients, slightly less cost $$
Ann: Trofinetide marketing application submitted in Europe, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.74 |
Change
1.200(9.57%) |
Mkt cap ! $1.702B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $9.711M | 709.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 172 | $13.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.75 | 53 | 2 |
View Market Depth
| Last trade - 12.55pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |